• Elegoo

  Participated · Series B · May 2026

  Founded in 2015 in Shenzhen, Elegoo began with STEM education kits and entered the 3D-printing market in 2018 with its Mars resin printer, which became a market success. The company claims a leading global position in shipments of LCD resin printers and is one of four major players—alongside Bambu Lab, Creality and Anycubic—that together control roughly 90% of the entry-level market. In 2025 Elegoo reported revenue of more than 2.3 billion yuan, growing over 30% year-over-year, with over 90% of that revenue from international markets. While resin printers remain a core product, Elegoo is increasingly targeting the FDM segment and has launched the Centauri-Carbon series, including a multi-color FDM model. Leadership, including CEO Chris Hong, has publicly stated an ambition to pursue a top global position in consumer 3D printing. Recent investments from DJI and Meituan are intended to add strategic technological and distribution capabilities to support the company’s product development and market expansion.

• dNovo Bio

  Participated · Seed · Jan 2022

  dNovo is developing a proprietary direct reprogramming system to generate personalized hair stem cells from patient-derived cells without passing through a pluripotent state. The company has converted human skin cells directly into induced hair stem cells and demonstrated those cells can produce hair in a mouse model. dNovo emerged from stealth and is optimizing its platform to scale the approach and work with potential partners. The team positions direct reprogramming as a quicker, scalable route compared with pluripotent-based methods. dNovo is pre-clinical and says the technology aims to replenish damaged or depleted hair stem cells to address the underlying cause of hair loss. The company was founded in 2018 and is based in San Jose, California.

No current team members are available.